Contact
Please use this form to send email to PR contact of this press release:
BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100
TO:
Please use this form to send email to PR contact of this press release:
BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100
TO: